Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This Phase 1 study will determine the safety, tolerability, and pharmacokinetics of
vinorelbine liposomes injection (VLI) in patients with advanced solid tumors, non-Hodgkin's
lymphoma, or Hodgkin's disease.